The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...

Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...

Non-animal testing methods could save drugmakers time and money, officials say ...

EC&M editors report from the trade show floor at the Nashville event and conduct short video interviews with subject matter ...

US FDA releases draft guidance on alternatives to animal testing in drug development: Silver Spring, Maryland Friday, March 20, 2026, 10:00 Hrs [IST] The US Food and Drug Administ ...

Study shows adaptive circuit breakers improve reliability, reduce failures, and enhance performance in complex distributed microservices systems under dynamic conditions.

CAMBRIDGE, England and MONTREAL, March 19, 2026 /PRNewswire/ -- CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre (R) Lung ...

The U.S. Food and Drug Administration has issued a draft guidance intended to help drug developers validate new approach methodologies to be used instead of animal testing ...

CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for ...

This FAQ outlines the technical methods used to identify and mitigate mismatches across the physical, mechanical, and circuit ...

Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling an openness to new approaches that haven’t been validated and the National ...

DESLOC today announced the launch of the K120 Smart Lock, a reliability-focused smart lock engineered for families and landlords who demand stability, long battery life, and fingerprint access that ...